RxDoctor Payments Data

Kirk Steehler, DO

Facial Plastic Surgery · Erie, PANPI 1588615447

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $882, 4.9 times the $181 reported in 2019.

$3,008in general payments, 2019–2025

Across 80 payments — averaging $37.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$598
  • Sanofi$355
  • Inspire Medical Systems, Inc.$349
  • Regeneron Healthcare Solutions, Inc.$230
  • Musculoskeletal Transplant Foundation Inc.$212
  • Smith+Nephew$211
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,008100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few facial plastic surgery providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$131,370
Medicare patients
654
Services billed
2,608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin81$3,589
Mometasone Furoate48$2,987
Famotidine249$1,542
Fluticasone Propionate159$1,431
Levothyroxine Sodium283$1,366
SynthroidLevothyroxine Sodium30$1,175
Meclizine Hcl87$927
Mupirocin147$872
Montelukast Sodium133$701
Triamcinolone Acetonide31$661
Omeprazole96$630
Pantoprazole Sodium79$405
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav45$319
Prednisone110$198
Tramadol Hcl66$88

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Erie

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →